Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Montelukast Oral Thin Film vs Chewable Tablet in Fed Healthy Volunteers
NCT05531994Phase 1Completed
- Sponsor
- Qilu Pharmaceutical
- Start
- Nov 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in asthma (2 arms), sponsored by Qilu Pharmaceutical. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve to Last Timepoint and 1 more. Started Nov 2018; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05531994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05531994.